Commonwealth Equity Services LLC Has $1.34 Million Stake in Teladoc Health Inc (TDOC)

Commonwealth Equity Services LLC decreased its holdings in shares of Teladoc Health Inc (NYSE:TDOC) by 25.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 27,121 shares of the health services provider’s stock after selling 9,257 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Teladoc Health were worth $1,344,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in TDOC. Vanguard Group Inc. raised its stake in shares of Teladoc Health by 26.9% in the 3rd quarter. Vanguard Group Inc. now owns 5,874,182 shares of the health services provider’s stock valued at $507,236,000 after buying an additional 1,244,388 shares in the last quarter. Vanguard Group Inc raised its stake in shares of Teladoc Health by 26.9% in the 3rd quarter. Vanguard Group Inc now owns 5,874,182 shares of the health services provider’s stock valued at $507,236,000 after buying an additional 1,244,388 shares in the last quarter. Riverbridge Partners LLC raised its stake in shares of Teladoc Health by 46.5% in the 4th quarter. Riverbridge Partners LLC now owns 1,229,038 shares of the health services provider’s stock valued at $60,923,000 after buying an additional 390,365 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Teladoc Health by 86.5% in the 4th quarter. Bank of New York Mellon Corp now owns 980,577 shares of the health services provider’s stock valued at $48,605,000 after buying an additional 454,702 shares in the last quarter. Finally, Victory Capital Management Inc. raised its stake in shares of Teladoc Health by 15.0% in the 4th quarter. Victory Capital Management Inc. now owns 881,132 shares of the health services provider’s stock valued at $43,678,000 after buying an additional 115,250 shares in the last quarter.

TDOC opened at $62.86 on Friday. The company has a quick ratio of 8.53, a current ratio of 8.53 and a debt-to-equity ratio of 0.41. The stock has a market capitalization of $4.32 billion, a price-to-earnings ratio of -43.65 and a beta of 1.44. Teladoc Health Inc has a 1-year low of $38.15 and a 1-year high of $89.05.

TDOC has been the subject of a number of recent analyst reports. Berenberg Bank initiated coverage on shares of Teladoc Health in a research report on Thursday, January 31st. They set a “buy” rating and a $80.00 target price for the company. Zacks Investment Research upgraded shares of Teladoc Health from a “hold” rating to a “buy” rating and set a $54.00 target price for the company in a research report on Saturday, January 5th. TheStreet upgraded shares of Teladoc Health from a “d+” rating to a “c” rating in a research report on Wednesday, February 20th. Cantor Fitzgerald reiterated a “hold” rating and set a $70.00 target price (down previously from $83.00) on shares of Teladoc Health in a research report on Wednesday, February 27th. Finally, Robert W. Baird upgraded shares of Teladoc Health from a “neutral” rating to an “outperform” rating and set a $80.00 target price for the company in a research report on Monday, January 14th. They noted that the move was a valuation call. Four analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. Teladoc Health has a consensus rating of “Buy” and a consensus target price of $81.84.

In other Teladoc Health news, CEO Jason N. Gorevic sold 30,000 shares of the firm’s stock in a transaction dated Wednesday, December 19th. The shares were sold at an average price of $49.55, for a total value of $1,486,500.00. Following the completion of the sale, the chief executive officer now owns 536,184 shares in the company, valued at approximately $26,567,917.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Michael Goldstein sold 20,500 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $63.40, for a total transaction of $1,299,700.00. Following the completion of the sale, the director now owns 21,418 shares of the company’s stock, valued at approximately $1,357,901.20. The disclosure for this sale can be found here. Insiders sold a total of 128,681 shares of company stock valued at $7,805,640 in the last 90 days. Corporate insiders own 3.95% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was published by American Banking News and is the property of of American Banking News. If you are accessing this report on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The original version of this report can be read at https://www.americanbankingnews.com/2019/03/17/commonwealth-equity-services-llc-has-1-34-million-stake-in-teladoc-health-inc-tdoc.html.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Recommended Story: Yield Curve

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply